Invention Grant
- Patent Title: 3α-hydroxysteroid dehydrogenase mutants and process for the preparation of ursodeoxycholic acid
-
Application No.: US16561643Application Date: 2019-09-05
-
Publication No.: US11306343B2Publication Date: 2022-04-19
- Inventor: Werner Hummel , Daniel Bakonyi
- Applicant: PharmaZell GmbH
- Applicant Address: DE Raubling
- Assignee: PharmaZell GmbH
- Current Assignee: PharmaZell GmbH
- Current Assignee Address: DE Raubling
- Agency: Saul Ewing Arnstein & Lehr LLP
- Agent Brian R. Landry; Justin W. Crotty
- Priority: EP14180614 20140812
- Main IPC: C12N9/04
- IPC: C12N9/04 ; C12N15/00 ; C12N15/53 ; C12N1/20 ; C12P33/00 ; C12P13/02 ; C12P33/02

Abstract:
The invention provides novel 3α-hydroxysteroid dehydrogenase mutants, sequences that code for these enzyme mutants, methods for producing the enzyme mutants, and the use thereof in enzymatic reactions of cholic acid compounds, and in particular in the production of ursodeoxycholic acid (UDCA). The invention further provides processes for the synthesis of UDCA using the enzyme mutants and the production of UDCA using recombinant microorganisms that have been subjected to multiple modifications.
Public/Granted literature
- US20190390242A1 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE MUTANTS AND PROCESS FOR THE PREPARATION OF URSODEOXYCHOLIC ACID Public/Granted day:2019-12-26
Information query